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While cattle in general have been identified as a reservoir of Escherichia coli O157:H7, there are limited data
regarding the prevalence and clonality of this pathogen in downer dairy cattle and the potential impact to
human health that may occur following consumption of meat derived from downer dairy cattle. In the present
study, conducted at two slaughter facilities in Wisconsin between May and October of 2001, we established a
higher prevalence of E. coli O157:H7 in fecal and/or tissue samples obtained aseptically from intact colons of
downer dairy cattle (10 of 203, 4.9%) than in those from healthy dairy cattle (3 of 201, 1.5%). Analyses of 57
isolates, representing these 13 positive samples (one to five isolates per sample), by pulsed-field gel electro-
phoresis, revealed 13 distinct XbaI restriction endonuclease digestion profiles (REDP). Typically, isolates from
different animals displayed distinct REDP and isolates from the same fecal or colon sample displayed
indistinguishable REDP. However, in one sample, two different, but highly related, REDP were displayed by the
isolates recovered. Antimicrobial susceptibility testing indicated that 10 of the 57 isolates, recovered from 2 (1
downer and 1 healthy animal) of the 13 positive samples, were resistant to at least 1 of 18 antimicrobials tested.
However, there was no appreciable difference in the frequency of resistance of isolates recovered from downer
and healthy dairy cattle, and not all isolates with the same REDP displayed the same antimicrobial suscep-
tibility profile. Lastly, it was not possible to distinguish between isolates recovered from downer and healthy
cattle based on their XbaI REDP or antimicrobial susceptibility. These results indicate that downer cattle had
a 3.3-fold-higher prevalence of E. coli O157:H7 than healthy cattle within the time frame and geographic scope
of this study.
Over the past 20 years, Escherichia coli O157:H7 has
emerged as a pathogen of significant public health concern in
the United States, causing an estimated 73,000 cases of infec-
tion and 61 deaths per year (24, 35). Although person-to-
person transmission has been documented, transmission of E.
coli O157:H7, in most cases, occurs through contaminated food
or water, with the consumption of raw or undercooked foods of
bovine origin being the most common route of food-borne
infection (25, 30, 39). Indeed, cattle are a primary reservoir of
this organism worldwide (7). Numerous studies (2, 4, 7, 11, 16)
have revealed that the organism is common in both dairy and
beef herds, with a prevalence of up to 75% in dairy herds (17)
and 63% in beef herds (18). The prevalence for individual
animals within herds in North America and Europe is esti-
mated at 1.8 to 16%, with levels as high as 36% being reported
(2, 8, 32). Due to the ubiquity of E. coli O157:H7 among cattle,
as well as its low infective dose and the severity of the resultant
illness in humans, effective control of the pathogen may be
possible only by eliminating this microorganism at its source
rather than by relying on proper food handling and cooking
thereafter. The development of intervention strategies at the
farm level is largely dependent on acquiring a better under-
standing of the ecology of E. coli O157:H7 strains and the
factors that facilitate their survival and dissemination. Eco-
logical data may also help determine whether the extent of
colonization of cattle is related to any specific farming or hus-
bandry practices. If such relationships were identified, modifi-
cations could be made to reduce the herd and/or animal prev-
alence of serotype O157:H7 strains of E. coli associated with
cattle.
Despite numerous investigations of cattle (2, 8, 17, 18, 32),
there are limited data regarding the prevalence, clonality, and
ecology of E. coli O157:H7 in dairy cattle with downer cow
syndrome, or downer cattle. The term “downer cattle” refers to
cattle that are suffering from assorted maladies, such as mas-
titis, calving paralysis, and milk fever, and/or injuries incurred
during transport which render them immobile to various de-
grees (3, 9) and which may require the administration of an-
timicrobials as treatment (1). If their condition does not im-
prove, these cattle are removed, or culled, from the production
herd (11, 34, 37). Culled dairy cows account for approximately
17% of the ground beef produced in the United States (37, 38).
Therefore, downer dairy cattle harboring E. coli O157:H7 at
slaughter may be an important source of contamination and
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may contribute appreciably to the health risk associated with
ground beef. Given the frequent association of E. coli O157:H7
with cattle and ground beef, as well as the use of downer and
dairy cattle for ground beef production, the present study was
conducted to gain insight on the comparative prevalence and
clonality of this pathogen in downer compared to healthy dairy
cattle in the upper Midwestern region of the United States.
Also, since downer dairy cattle may receive antimicrobials as
treatment for various maladies, and since it is generally ac-
cepted that the frequent use of antimicrobials in animal hus-
bandry is implicated in accelerating the development of patho-
gens that are resistant to such antimicrobials, another objective
of the present study was to establish the comparative suscep-
tibility of isolates recovered from downer and healthy animals
to a panel of antimicrobials.
(Portions of this research were presented at the Annual
Meeting of the International Association for Food Protection,
30 June to 3 July 2002, San Diego, Calif. [C. M. Byrne, I. Erol,
J. E. Call, D. Buege, C. W. Kaspar, C. Hiemke, P. Fedorka-
Cray, J. Hermosillo, T. Ball, A. K. Benson, F. M. Wallace, M.
Handy, and J. B. Luchansky, Abstr. Annu. Meet. Int. Assoc.
Food Prot., abstr. 136, p. 92, 2002].)
MATERIALS AND METHODS
Sample design and collection. This study was conducted at two beef processing
facilities, designated plant A and plant B, in Wisconsin between May and Oc-
tober of 2001. Plant A (four visits) primarily processed healthy dairy cattle, that
is, cattle with no obvious maladies, while plant B (seven visits) primarily pro-
cessed dairy cattle with downer cow syndrome. At plant A, attempts were made
to collect samples from healthy cows rather than from steers, whereas at plant B
all samples collected from downer cattle were from cows. Both plants received
cattle primarily from three states (Illinois, Iowa, and Wisconsin) in the upper
Midwest region of the United States. For a given visit, the downer cattle included
animals, usually obtained by “collectors,” from several farms. A collector is a
business that transports animals for a farmer to slaughter for a fee. In contrast,
for a given visit, healthy animals likely came from a common feedlot. At each visit
to a plant, 21 to 65 samples, mostly fecal material but also some tissue material,
were aseptically collected directly from intact colons for analyses, for a total of
201 and 203 fecal or tissue samples from downer and healthy cattle, respectively.
Fecal or tissue samples (10 to 50 g) were obtained aseptically from intact colons
by using sterile knives to open the colon. A sterile tongue depressor was then
used to remove the colon contents and transfer them to a sterile receptacle.
Samples were stored on ice before being transported to the laboratory and
analyzed within 6 h of collection.
Microbiological analyses. Fecal and tissue samples were tested for E. coli
O157:H7 by enrichment and immunomagnetic separation, according to the pro-
cedure of Chapman et al. (6), with the following modifications. Briefly, a 10-g
sample of feces and/or colon tissue was homogenized and enriched in 90 ml of
EC broth (Fisher Scientific, Pittsburgh, Pa.) containing novobiocin (20 g/liter;
Sigma Chemical Co., St. Louis, Mo.). The suspension was incubated at 37°C for
18 h, followed by immunomagnetic separation as follows: a 20-l volume of
anti-O157 immunomagnetic beads (anti-E. coli O157 Dynabeads; Dynal, Lake
Success, N.Y.) was added to a microcentrifuge tube containing 0.5 ml of EC
broth and 0.5 ml of phosphate-buffered saline (pH 7.2; Fisher) containing Tween
20 (0.05%; Sigma) (PBS-Tween 20), incubated at 25°C for 10 min on a platform
rocker (60 cycles per min), and separated in a magnetic particle concentrator
(MPC-S; Dynal). The immunomagnetic beads were washed three times in 1 ml
of PBS-Tween 20. Fifty microliters of the bead suspension was then spread
plated onto sorbitol MacConkey (Fisher) agar plates containing cefixime (0.5
mg/liter; Sigma) and potassium tellurite (2.5 mg/liter; Difco). After an 18-h
incubation at 37°C, sorbitol-negative colonies were tested for the O157 and H7
antigens by latex agglutination with a RIM E. coli O157:H7 test kit (Remel,
Lenexa, Kans.). Sorbitol-negative, latex-positive colonies were biochemically
confirmed as E. coli by using API 20E biochemical identification strips as di-
rected by the manufacturer (bioMérieux Vitek Inc., Hazelwood, Mo.). Up to five
confirmed serotype O157:H7 isolates from each positive sample were retained
for further characterization.
Molecular characterization via the PCR. Each isolate was further character-
ized for the presence of sequences encoding the somatic O157 antigen (rfbO157),
the H7 flagellar antigen (fliCH7), Shiga toxin 1 (stx1), Shiga toxin 2 (stx2), the
intimin protein (eaeA), and hemolysin (hly933) by the PCR method essentially as
described by Fratamico et al. (12). E. coli O157:H7 strain 933 was used as a
positive control, while sterile, distilled, water was used as a negative control.
Molecular subtyping via PFGE. Each E. coli O157:H7 isolate was subtyped by
the pulsed-field gel electrophoresis (PFGE) technique of contour-clamped ho-
mogeneous electric field (CHEF) electrophoresis as previously described (19).
Genomic DNA was digested in agarose plugs with XbaI (Promega Corp., Mad-
ison, Wis.) as recommended by the manufacturer. The resulting DNA fragments
were resolved by CHEF-PFGE with a CHEF-DRII apparatus (Bio-Rad Labo-
ratories, Richmond, Calif.) at 200 V for 19 h at 14°C and switch times from 1 to
60 s. Low-range lambda concatemers (Promega) were used as DNA size stan-
dards. The fragments were visualized by using ethidium bromide (10 g/ml;
Bio-Rad) and short-wave UV light, and the image was captured by a Gel Doc
1000 system (Bio-Rad). The presence, absence, and similarity of restriction
fragments were ascertained visually.
Susceptibility testing with Sensititre. All E. coli O157:H7 isolates were tested
for susceptibility to 18 antimicrobials by using a custom-made panel on a semi-
automated broth microdilution system (Sensititre; Trek Diagnostics, Westlake,
Ohio) as per the manufacturer’s instructions. The 18 antimicrobials used were
amikacin, amoxicillin/clavulanic acid, ampicillin, apramycin, cefoxitin, ceftiofur,
ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, gentamicin, imipenem,
kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, and tri-
methoprim/sulfamethoxazole. National Committee for Clinical Laboratory Stan-
dards guidelines (27, 28) were followed, and the antimicrobials were used in
concentrations previously described by the National Antimicrobial Resistance
Monitoring System (http://www.arru.saa.ars.usda.gov). The only exception was
imipenem, which was used at 0.25 to 8.0 g, with breakpoints of 4 g/ml for
sensitivity and 16 g/ml for resistance.
Statistical analyses. Statistical differences between the prevalence of E. coli
O157:H7 in downer and healthy cattle were determined with Student’s t test. The
percentages of downer and healthy cattle positive for E. coli O157:H7 were
compared by calculating z values for proportions in independent samples (33).
RESULTS
Analyses of 404 fecal samples from dairy cattle at slaughter
facilities in Wisconsin revealed that 13 samples contained E.
coli O157:H7 and established a 3.3-fold-higher prevalence of
this pathogen in downer cattle (10 of 203; 4.9%) than in
healthy cattle (3 of 201; 1.5%) (Table 1). The observed differ-
ence was not statistically significant at a P value of 0.06. Re-
gardless, a total of 57 isolates, 15 from healthy animals and 42
from downer animals, were retained for further analyses by
selecting up to 5 isolates at random from each of the 13 pos-
itive samples. For the purposes of this study, isolates described
herein with indistinguishable PFGE patterns, virulence geno-
types, and antimicrobial susceptibility profiles recovered from
the same sample were considered a single clone.
Analyses of these 57 isolates by PFGE revealed 13 distinct
XbaI restriction endonuclease digestion profiles (REDP) (Ta-
ble 1). With one exception, i.e., fecal samples 27 and 31 from
1 May 2001 that both displayed REDP 5, isolates from differ-
ent animals displayed distinct REDP. In addition, isolates from
the same fecal sample or animal typically displayed indistin-
guishable REDP, with the exception of isolates from sample
45, which displayed two different but highly related XbaI
REDP. Highly related isolates showed only a one- or two-band
difference among approximately 20 total XbaI fragments.
Characterization of the 57 E. coli O157 isolates by PCR
revealed that all were positive for fliCH7 and displayed four
profiles based on the presence or absence of the virulence
sequences tested as follows: (i) 38 of the 57 isolates (67%) had
sequences for all four virulence genes tested, namely, Shiga
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toxin 1 (stx1), Shiga toxin 2 (stx2), intimin (eaeA) and hemolysin
(hly); (ii) 11 of the 57 isolates (19%) had stx1, eaeA, and hly
sequences but not stx2 sequences; (iii) 5 of the 57 isolates (9%)
were missing stx1 sequences but had the sequences for all of the
other virulence factors tested; and (iv) 3 of the 57 isolates (5%)
had all of the virulence sequences tested for, with the exception
of hly. In general, isolates with the same REDP had the same
virulence genes. There was one exception: two of the five
isolates displaying REDP 8 (isolates MFS 764 and MFS 765)
had the gene sequence for hemolysin, while the other three
isolates (MFS 761, MFS 762, and MFS 763) did not.
The majority (47 of 57; 81%) of the isolates tested were
sensitive to all 18 antimicrobials tested. However, 10 of 57
(18%) of these E. coli O157:H7 isolates (5 isolates from
healthy cattle and 5 from downer cattle), representing two
distinct XbaI REDP (one from healthy cattle and one from
downer cattle), were resistant to at least 1 of the 18 antimicro-
bials tested. Indeed, 6 of these 11 isolates were resistant to
three antimicrobials, sulfamethoxazole, streptomycin, and tet-
racycline. Not all isolates displaying a distinct XbaI REDP
displayed the same antimicrobial resistance profile. For exam-
ple, of the five isolates displaying REDP 1, four were resistant
to sulfamethoxazole, streptomycin, and tetracycline while one
was resistant to only sulfamethoxazole and tetracycline.
DISCUSSION
Serotype O157:H7 strains of E. coli remain a serious threat
to public health and an appreciable economic burden to the
food industry. Numerous studies have shown that cattle and
food produced therefrom, particularly ground beef, are signif-
icant sources and vehicles of transmission of this pathogen.
However, relatively little has been published on the recovery
and clonality of E. coli O157:H7 strains from downer dairy
cattle (8, 22, 35). Although precise numbers are not available,
downer animals constitute about 1.5% of dairy cattle (15) and
20 U.S. Department of Agriculture-inspected plants slaughter
at least 100 cows per day, most of which are downer animals
(Robert E. Brewer, personal communication). The present
study established an approximate 3.3-fold-higher prevalence of
E. coli O157:H7 in downer dairy cattle (4.9%) than in healthy
dairy cattle (1.5%) processed at two slaughter facilities during
our sampling period. To our knowledge, this is the first inves-
tigation of the recovery and clonality of this pathogen in
downer dairy cattle. In a similar study investigating E. coli
O157:H7 in fecal pats in home pens of healthy cattle (0.24%
positive samples among 12,718 total samples) versus hospital
pens of sick cattle (0.29% positive samples among 3,144 total
samples), Galland et al. (13) reported no significant difference
in the prevalence of the pathogen between these two groups.
Differences in experimental design and methodologies em-
ployed may be responsible for the differences in isolation fre-
quency reported in the present study and the study by Galland
and colleagues.
The recovery rate of about 1.5% for E. coli O157:H7 in
healthy dairy cattle in the present study is in agreement with
results reported for healthy dairy cattle in other studies con-
ducted in the United States (2, 11, 13, 22, 38). For example, the
TABLE 1. Characteristics of E. coli O157:H7 isolates found in fecal and colon samples of cattle at slaughter
Plant
(cattle
type)
Collection
date
(mo/day/yr)
No. of E. coli
O157:H7-positive
fecal samples/
total (%)
Positive
fecal sam-
ple no.
No. of iso-
lates from
positive
samplea
MFS
isolate
no.b
PCR profile
(virulence genes
present)c
PFGE
profiled (no.
of isolates)
Antimicrobial
susceptibility profilee
A (healthy) 05/08/01 2/33 19 5 724–728 stx1, stx2, eae, hly 1 (5) Sulfa, Tet (MFS 724) Strep Sulfa,
Tet (MFS 725–MFS 728)
21 5 729–733 stx1, stx2, eae, hly 2 (5) Pan-sensitive
06/12/01 0/53
07/03/01 1/65 45 5 739–743 stx1, stx2, eae, hly 3 (4), 4 (1) Pan-sensitive
07/24/01 0/50
Total 3/201 (1.5)
B (downer) 05/01/01 2/25 27 1 744 stx1, eae, hly 5 (1) Pan-sensitive
31 1 745 stx1, stx2, eae, hly 5 (1) Pan-sensitive
06/05/01 1/30 23 5 746–750 stx1, eae, hly 6 (5) Sulfa, Tet (MFS 746, MFS 747,
and MFS 749)
Strep, Sulfa, Tet (MFS 748 and
MFS 750)
06/19/01 1/21 20 5 751–755 stx1, stx2, eae, hly 7 (5) Pan-sensitive
07/17/01 1/33 28 5 761–763 stx1, stx2, eae 8 (5) Pan-sensitive
764–765 stx1, stx2, eae, hly
09/11/01 3/28 7 5 766–770 stx1, stx2, eae, hly 9 (5) Pan-sensitive
18 5 771–775 stx1, stx2, eae, hly 10 (5) Pan-sensitive
22 5 776–780 stx1, stx2, eae, hly 11 (5) Pan-sensitive
10/02/01 2/24 8 5 781–785 stx2, eae, hly 12 (5) Pan-sensitive
10/09/01 0/42 11 5 786–790 stx1, eae, hly 13 (5) Pan-sensitive
Total 10/203 (4.9)
a Number of isolates from one positive fecal/colon sample, following enrichment, plating, and analysis by PFGE.
b Internal isolate numbers from the Microbial Food Safety (MFS) Research Unit collection.
c Virulence factors tested for were Shiga toxin 1 and 2 (stx1 and stx2), intimin protein (eae), and hemolysin (hly).
d PFGE profile generated with XbaI.
e Strep, streptomycin; Sulfa, sulfamethoxazole; Tet, tetracycline.
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U.S. Department of Agriculture National Animal Health Mon-
itoring System Dairy 1996 study reported an E. coli O157:H7
prevalence of 1.8% among 2,200 culled dairy cows at 97 mar-
kets across the United States (38). Similarly, McDonough et al.
(22) reported a prevalence of 1.3% in culled dairy cows in New
York State. However, other studies have reported much higher
recovery rates of the pathogen in both beef and dairy cattle.
For example, Chapman (8) reported a prevalence rate of 16%
among 1,661 culled dairy cattle over a 1-year period. Similarly,
Elder et al. (10) demonstrated an overall prevalence of entero-
hemorrhagic E. coli O157 (E. coli O157:H7 and O157:H/
nonmotile) of 28% from feces (91 of 327 samples across 29 lots
of animals) and 11% on hides (38 of 355 samples across 29 lots
of animals) from fed cattle from 29 single sources (lots) pre-
sented for slaughter at processing plants in the Midwestern
United States in July and August of 1999. The latter studies
indicate that the overall prevalence of E. coli O157 (enterohe-
morrhagic E. coli O157:H7 and O157:H) in cattle may be
significantly higher than prior estimates. This may be the result
of improved enrichment and isolation procedures, notably im-
munomagnetic separation. Variations among studies may also
be due to differences in the numbers of cattle sampled, the type
of sample and how it was collected, and the age of the animals
sampled, as well as in the patterns of E. coli O157:H7 shedding
by animals, which are known to be intermittent (5). It may also
be attributed, in part, to the experimental design and to sea-
sonality (14). Fecal shedding of E. coli O157:H7 is more com-
mon in the warmer months of the year, namely, June to Sep-
tember (5, 7). Therefore, sampling plans that include only
these times of the year will result in higher recovery rates than
studies reporting average recovery rates, which may include
results for colder months (14). Furthermore, single-time-point
samples, such as those used in other studies, provide only
limited information regarding shedding of organisms. The
present study was conducted from May to October of 2001,
when bovine fecal shedding of E. coli O157:H7 is probably
highest, and it employed the most sensitive isolation tech-
niques available; therefore, seasonality and methodology alone
cannot be used to explain the difference between the recovery
rate reported herein and those reported by other investigators.
It should also be noted that the results herein refer to recovery
of serotype O157:H7 strains. However, serotype O157:H iso-
lates were also recovered from at least two samples in this
study, one each from downer and healthy cattle (data not
shown). Therefore, if the present study had included methods
for the detection of serotype O157:H strains in addition to
serotype O157:H7 strains, the overall prevalence, that is, the
total number of both O157:H and O157:H7 isolates, might
have been slightly higher.
Molecular subtyping techniques, such as PFGE, have been
widely used to investigate the ecology of E. coli O157:H7 at
various points along the food chain. In the present study,
analyses of multiple colonies from each of the 13 E. coli O157:
H7-positive samples revealed 13 distinct XbaI REDP. In gen-
eral, isolates from different fecal samples had different REDP.
However, in one instance, isolates from two separate fecal
samples (from downer cattle) had the same REDP and were
recovered from samples 27 and 31 on 1 May 2001. Although it
is not possible to match each cow with a source (farm), the two
cows harboring O157:H7 strains with a common REDP may
have been from a common farm, as truckers usually trans-
ported 3 to 10 downer cattle, collected from various farms, to
the slaughter plant. Analyses of multiple isolates from a posi-
tive animal revealed that some animals harbored E. coli
O157:H7 strains that had different, although similar, REDP.
The levels of similarity among strains found in this study indi-
cate that there may have been genetic changes, such as the loss
of a plasmid or phage, which resulted in minor changes in the
REDP, as reported by other investigators (11, 13, 21, 26, 32).
In general, isolates displaying a distinct XbaI REDP had the
same antimicrobial susceptibility profile. However, there were
several exceptions to this, raising the possibility that although
the REDP data suggest clonality of isolates, as evidenced by
differences in antimicrobial susceptibility patterns, mixed pop-
ulations exist within the same animal. The results of the
present study are in agreement with the results of Meng et al.
(26), who, while investigating isolates from the 1993 outbreak
of E. coli infection from ground beef in the western United
States, found that although all nine isolates had indistinguish-
able REDP, only two were resistant to streptomycin, sulfa-
methoxazole, and tetracycline. The researchers attributed this
to the fact that genes encoding antimicrobial resistance are
often carried on plasmids and genomic DNA fingerprinting
methods, such as PFGE, are not sufficiently discriminatory to
recognize subtle differences on plasmids.
Researchers have speculated that the use of antimicrobials
to promote animal performance and well-being has played a
role in accelerating the development of antimicrobial-resistant
pathogens (20, 29, 32, 40). Therefore, we anticipated a differ-
ence in the susceptibility of isolates recovered from healthy
versus downer dairy cattle, hypothesizing that bacteria from
downer cattle might be more resistant due to the probability of
increased antimicrobial use. In contrast, healthy cows are not
routinely treated with antimicrobials while producing milk
(23). However, there was no appreciable difference in the fre-
quency of antimicrobial resistance of isolates recovered from
healthy and downer cattle, suggesting that antimicrobial use
practices between the two groups had no significant effect on
the development of resistance. It is possible that farmers are
not administering antimicrobials to downer dairy cattle be-
cause of cost, declining profits, larger numbers of animals per
farm, and/or more rapid turnover of milking cows. The latter
scenario would explain, at least in part, why there was not a
statistically significant difference in antibiotic resistance be-
tween isolates from healthy and downer animals. Regardless,
the results of the present study concur with those of a previous
study by Galland et al. (13), who demonstrated that there was
no difference in the antimicrobial resistance profiles between
cattle in home pens and those in hospital pens, where antimi-
crobial use was presumably higher.
Of the 57 E. coli O157:H7 isolates tested, 10 (18%) were
resistant to at least 1 of the 18 antimicrobials tested. Strepto-
mycin, sulfamethoxazole, and tetracycline were the three anti-
microbials to which resistance was displayed, with resistance to
tetracycline and sulfamethoxazole occurring more often. The
results of the present study are in agreement with those of
Meng et al. (26), who reported that 24% of the E. coli O157:H7
isolates tested were resistant to at least one antimicrobial, with
greatest resistance to streptomycin and tetracycline. Schroeder
et al. (31) also reported that among 189 E. coli O157:H7
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isolates recovered from various sources between 1985 and
2000, 19 (10%) were resistant to sulfamethoxazole and 16
(8%) were resistant to tetracycline. These two antimicrobials
are commonly used to treat respiratory infections, diarrhea,
mastitis, and other infections in beef and dairy cattle (29). Use
of these or any antimicrobial for therapeutic or nontherapeutic
indications may exert selective pressure and result in the de-
velopment and maintenance of serotype O157:H7 strains of
E. coli that are resistant to these and related antimicrobials.
Further, these three antimicrobials have been used in veteri-
nary and human medicine for decades and the genes which
encode these antimicrobials are commonly found on plasmids,
thus making it possible for the organism to more readily ac-
quire resistance to these antimicrobials. Other classes of anti-
microbials, including penicillins and cephalosporins, are also
used to treat disease in cattle (29). Interestingly, the majority
of E. coli O157:H7 isolates, including those in the present
study, remain susceptible to these antimicrobials. Comparison
with generic E. coli indicates greater resistance among non-
O157:H7 E. coli strains, suggesting that E. coli O157:H7 is re-
fractory to developing resistance. The use of antimicrobials to
treat E. coli O157:H7 is a contentious area in the management
of infection and is currently contraindicated, as it may exacer-
bate the disease (36).
The present study provided further insight into the ecology
of E. coli O157:H7 in downer dairy cattle. The influence of
geography and seasonality notwithstanding, we observed a 3.3-
fold-higher prevalence of serotype O157:H7 strains of E. coli in
downer than in otherwise healthy dairy cattle. However, there
was no appreciable difference in the prevalence or frequency of
antimicrobial resistance among E. coli O157:H7 isolates recov-
ered from downer and healthy dairy cattle. Regarding the
former, although not statistically significant, our study dem-
onstrated a higher prevalence of serotype O157:H7 strains of
E. coli in downer than in healthy dairy cattle. Considering the
P value (0.06), additional studies that include a larger number
of animals, a broader geographic scope, and an extended sam-
pling period are needed to determine if the difference we
observed in our initial study is indeed significant. If further
studies show that downer dairy cattle have a significantly
higher prevalence of this pathogen than healthy cattle, perhaps
some consideration should be given to exclude downer or sus-
pect animals from the meat supply or to channel such animals
into cooking operations. Also, studies to ascertain if the num-
bers and duration of shedding of this pathogen in downer dairy
cattle differ from those of healthy dairy cattle would be highly
beneficial. The validation of such a relationship would provide
a potential intervention target for the control of E. coli
O157:H7 on farms.
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